Patient-Specific Factors: Unique circumstances making GLP-1 the best choice (e.g., comorbidities, allergies)
Searches for Mounjaro and Zepbound skyrocketed between 2024 and 2025, with over 1.5 million Brits now taking a weight-loss drug (a share that has nearly doubled in this period)
The combination of GLP-1 and TRT should be personalized
However, Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management
Past history of obesity triggers persistent epigenetic changes in innate immunity and exacerbates neuroinflammation
When NAD+ levels drop, cellular repair processes can slow down, often leading to common signs of aging like decreased physical energy, slower recovery times, and what many people describe as "brain fog." Key Takeaway: NAD+ is primarily focused on cellular energy and repair